Medicalised Beauty Market China 2011

Countries covered: China Chinese women want flawless skin and have exacting standards. This pursuit of perfect skin has created a huge market for products and treatments. More recently, consumers have enthusiastically embraced aesthetic medicine as a very effective way of delivering desired outcomes - blemish-free skin and altered facial features (eyes) or enhanced body parts. Demand outstrips supply. Sales are forecast to increase by 40% over the next three years alone. Buyers of medicalised beauty remain cautious as industry regulations have not kept up with technology developments. The premium segment is the reference point and these clinics and their consumers want foreign technology and brands which can offer quality guarantees.

Additional Information

Skincare reigns supreme in China. Chinese women are prepared to pay for effective facial care products and treatments because they want perfect skin and have very exacting standards. They spend proportionately more per capita on skincare than their Caucasian counterparts. The skincare category accounts for most of the personal care market in China which is also one of the largest world markets for luxury skincare products.

A huge industry has developed to meet high consumer demand for skincare. Spa chains, which combined have many tens of thousands of units nationally, provide routine skincare treatments and, in addition, their VIP spas offer a range of minor and not so minor aesthetic procedures.

But it does not stop there. Chinese women, in their quest for perfect skin and enhanced beauty, have enthusiastically embraced aesthetic medicine. Technology and science - whether lasers/IPL, fillers or cosmetic surgery - are recognised as very effective ways of delivering the desired outcomes. These can be a blemish-free skin and altered facial features (eg Asian eye procedure) or body parts (eg, breast enhancements).

Artificial beauty is now widely accepted by Chinese society, especially urban dwellers. It is fair to say that cosmetic surgery is now viewed as a quite normal procedure much like teeth straightening is regarded in the west. The beauty market in China is a predominantly young market. The pursuit of a flawless skin rather than anti-ageing (eg, prevention or removal of lines) is the main driver in contrast to more mature US and European markets.

Demand for medicalised beauty now outstrips supply. Sales of invasive and non-invasive treatments are forecast to increase by almost 40% over the next three years according to new research published by Diagonal Reports. The aesthetics industry in China is gearing up to meet this higher demand. Some of the Chinese laser clinic chains interviewed by Diagonal Reports plan to double the number of units they operate. This expansion will take place outside the tier-one cities.

The premium segment accounts for almost a quarter of the value of the medicalised beauty market. These clinics can command up to a 100% price premium for their cosmetic surgery procedures. The importance of this segment is due to a number of factors. The main issues are that consumers feel they lack protection as regulations have yet to catch up with an industry still in its infancy and they also fear the consequences of botched procedures.

Foreign companies and brands, which can guarantee the highest of quality standards and the best technology, are knocking on an open door.

This new research report Chinese Medicalised Beauty Market 2011 focuses on demand for lasers/IPL, fillers and cosmetic surgery in China.

More China Dermatology Reports

China Dermatitis Prescription Drug Sales Data 2006-2010 by Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...

Medicated Skin Products in the BRIC (Brazil, Russia, India, China) Countries - Market Overview and Forecasts to 2014 by Datamonitor
Introduction This report covers key aspects of the medicated skin products market in four emerging / high growth economies: Brazil, Russia, India and China. Data ...

Medicated Skin Care - China by Euromonitor International
Medicated skin care is one of the most important categories in China’s OTC market, accounting for 21% of total OTC market size. Sales of medicated ...

Chinese Markets for Skin Cancer Treatment Drugs by Asia Market Information & Development Company
China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and ...

Study on the Present Situation of China's Skin Disease Drug Market by SunFAITH China Ltd.
In China, skin disease is a common and frequent disease. Total incidence of skin disease in China is 1.23%, i.e. about 16 million people, which ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Juice – China – a snapshot (2010) by Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...

See all reports like this >>